awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30248296-5AFCFC93-527E-4962-B64E-94799A4A6442
Q30248296-5AFCFC93-527E-4962-B64E-94799A4A6442
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30248296-5AFCFC93-527E-4962-B64E-94799A4A6442
Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials.
P2860
Q30248296-5AFCFC93-527E-4962-B64E-94799A4A6442
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30248296-5AFCFC93-527E-4962-B64E-94799A4A6442
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e596b3110e64c095ae8de2e3e0927eba13a090e
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.